Login to Your Account



Regulatory NEWS
HONG KONG – The CFDA is getting closer to completing a new revision of the country's Pharmaceutical Administration Law. After drastically increasing the registration fees for pharmaceuticals this year, the CFDA is now soliciting opinions on a draft guideline for the registration inspection of imported pharmaceutical products.

The answer to reducing the cost and time of developing drugs for unmet needs seems pretty obvious – a better understanding of the disease, the patient and the molecule being developed.

BOGOTA, Colombia – Biosimilar makers and distributors are looking at the small but growing markets in Latin America to not only reach new consumers, but also pave the way for entry into more developed markets.
More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: